Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
Noosa News13 hours agoMassive wind farm project in Queensland axed amid community backlash
-
Business17 hours agoIAG shares are racing higher today. Here’s why
-
Noosa News14 hours agoProp Allan Alaalatoa returns to the Wallabies line-up for Rugby Championship game against Argentina
-
General18 hours agoQueensland government dumps Forest Wind project